Etiologics Ltd., of Oxford, UK, appointed David Campbell chief scientific officer.

EvoGenix Pty Ltd., of Sydney, Australia, appointed Hennie Hoogenboom as an adviser.

Ganeden Biotech Inc., of Cleveland, appointed Philip Ginsburg medical director.

Genaissance Pharmaceuticals Inc., of New Haven, Conn., promoted Carol Reed to vice president, medical affairs.

Genomics Collaborative Inc., of Cambridge, Mass., named Gregory Sullivan director of business development and sales.

Graffinity Pharmaceuticals AG, of Heidelberg, Germany, appointed Achim Feurer director of medicinal chemistry.

ICN Pharmaceuticals Inc., of Costa Mesa, Calif., appointed Wesley Wheeler president, North America.

Lifeline Biotechnologies Inc., of Reno, Nev., added Marta Rendon to its medical advisory board.